Clinical trial
FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in…
NCT00293670 · Tampere University, Other · Unknown status
Key facts
| NCT number | NCT00293670 |
|---|---|
| Title | FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer |
| Official title | Intermittent Vs Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer |
| Lead sponsor | Tampere University, Other |
| Collaborators | Finnish Prostate Cancer Group |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Patients With T1-4 Advanced Prostate Cancer |
| Intervention type | Drug |
| Interventions | Goserelin (Zoladex) |
| Enrollment | 573 |
| Start date | May 1, 1997 |
| Completion | Apr 1, 2015 |
| First posted | Feb 17, 2006 |
| Last update posted | Feb 17, 2006 |
| Countries | Finland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: